The Food and Drug Administration has approved the world’s first medicine based on CRISPR gene-editing technology, a ...

Many high risk, high reward medical therapies that use cutting edge science are proving themselves in clinical trials. But are health services ready to pay for them—and how? Marianne Guenot reports On ...

Following a breakthrough 'cure' for sickle cell disease being approved on the NHS, the Mirror sat down with four British ...

When even one tiny section of a person’s genetic code becomes mutated or modified, cells can begin to act out of ...

While de-extinction projects capture headlines with dreams of resurrecting mammoths, the same technologies at play — especially CRISPR — are quietly transforming something even more profound: human ...

Bluebird Bio and Xcellbio have entered into an agreement to support the commercialization of sickle cell gene therapy ...

Sickle cell disease, characterised by the abnormal sickle shape of red blood cells instead of the typical round form, is the UK's most rapidly expanding genetic disorder. This deformation causes ...

Groundbreaking gene-editing treatment exa-cel is now available for NHS patients with sickle cell disease, offering a ...

Investigators have developed STITCHR, a new gene editing tool that can insert therapeutic genes into specific locations without causing unwanted mutations. The system can be formulated completely as ...

A federal district court had ruled in favor of HHS, restricting Vertex's ability to provide fertility preservation services to Medicaid patients.

Gene editing technologies have cemented their place as a valued method in the biological toolkit used by researchers around the globe.